|
HY-14174-10mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-100mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-5mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-50mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-1mL
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-P1827-1mg
|
MedChemexpress LLC
|
mTRP-2 (180-188) [CAS 219312-69-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P1827-10mg
|
MedChemexpress LLC
|
mTRP-2 (180-188) [CAS 219312-69-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P1827-5mg
|
MedChemexpress LLC
|
mTRP-2 (180-188) [CAS 219312-69-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P1052A-1mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240A-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P0003-1mg
|
MedChemexpress LLC
|
Nesiritide [CAS 124584-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P0003-10mg
|
MedChemexpress LLC
|
Nesiritide [CAS 124584-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P0003-5mg
|
MedChemexpress LLC
|
Nesiritide [CAS 124584-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P1026-1mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1026-10mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1026-25mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1026-5mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2185A-1mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
